OSTHOLE SYNERGIZES WITH HER2 INHIBITOR, TRASTUZUMAB IN HER2-OVEREXPRESSED N87 GASTRIC CANCER BY INDUCING APOPTOSIS AND INHIBITION OF AKT-MAPK PATHWAY

Osthole Synergizes With HER2 Inhibitor, Trastuzumab in HER2-Overexpressed N87 Gastric Cancer by Inducing Apoptosis and Inhibition of AKT-MAPK Pathway

Background and Purpose: Although trastuzumab has shown considerable activity in the treatment of HER2-positive breast and gastric cancers, a significant proportion of patients do not respond to trastuzumab.Recent studies revealed that osthole, an active coumarin isolated from Cnidium monnieri (L.) Cusson possesses potent anti-tumor activity.Here, w

read more